Empaxo M 12.5/500mg Tablet is a combination medication containing two active ingredients: Empagliflozin & Metformin Hydrochloride. It is prescribed for the management of type 2 diabetes mellitus to help control blood sugar levels.
Components:
- Empagliflozin: Belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. It works by reducing the reabsorption of glucose in the kidneys, leading to increased urinary excretion of glucose and lower blood sugar levels.
- Metformin Hydrochloride: Falls under the category of biguanide antidiabetic agents. It helps decrease the production of glucose in the liver and improves the body’s response to insulin, enhancing the utilization of glucose by cells.
Uses:
Empaxo M 12.5/500mg Tablet is indicated for the treatment of type 2 diabetes mellitus. It helps control blood sugar levels and may be prescribed as part of a comprehensive diabetes management plan, including diet and exercise.
Side Effects: Common side effects may include urinary tract infections, increased urination, and gastrointestinal symptoms. Serious side effects are rare but may include lactic acidosis (with Metformin) and genital yeast infections (with SGLT2 inhibitors). Report any unusual or severe side effects to your healthcare provider.
Precautions:
- Inform your healthcare provider about any pre-existing medical conditions, especially kidney problems or a history of lactic acidosis.
- Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
- Monitor for signs of dehydration, particularly if there are episodes of vomiting or diarrhea.
When Not to Use:
Empaxo M 12.5/500mg Tablet may not be suitable for use in the following situations:
- Known hypersensitivity or allergy to Empagliflozin, Metformin, or any components of the medication.
- Severe renal impairment or end-stage renal disease.
- History of lactic acidosis, ketoacidosis, or diabetic ketoacidosis.
Reviews
There are no reviews yet.